Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/16887291

Int. J. Radiat. Oncol. Biol. Phys. 2006 Oct 1 66 2 408-15

Download in:

View as

General Info

PMID
16887291